- Funding innovation with a ‘One Health’ or ‘dual-benefit’ proposition – vaccines, diagnostics, etc.- How do we define the market for products with a downstream value proposition, who pays for these interventions? - Who are the early adopters and what are the drivers? - Integrating environmental vaccines into animal health frameworks - Global equity: will LMIC producers be left behind or lead innovation?- Innovation with dual human/animal benefit.